We are monitoring the impact of COVID-19 on Middle East & Africa Cardiac Marker Testing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 4808
Share on
Share on

Middle East & Africa Cardiac Marker Testing Market Research Report – Segmented By Type, Product, Disease, Testing & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Growth, Trends & Forecasts (2021 to 2026)

Pulished: April, 2021
ID: 4808
Pages: 145

Middle East & Africa Cardiac Marker Testing Market Size & Growth (2021 to 2026):

As Per the Report, the Middle East & Africa Cardiac Marker Testing Market Size is anticipated to grow at 5.26% CAGR from 2021 to 2026 and it is estimated that the market is valued at USD 0.22 billion in 2021 and is expected to reach USD 0.29 billion by 2026.

Cardiac markers are biomarkers used to measure and evaluate heart function. They are primarily discussed in reference to myocardial infarction, but other conditions can lead to an elevation in the cardiac marker level. Most of the early markers identified were enzymes, and as an effect of that, the term "cardiac enzymes" is used every now and then. Be that as it may, not all of the markers are presently used are enzymes.

Factor such as an increase in the incidence and occurrences of cardiovascular diseases is among the main factors driving the market growth.  Furthermore, a number of factors such as growing instances of cardiovascular diseases, the rapidly increasing geriatric population, growing to fund from public-private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers are driving the growth of the cardiac marker testing market. On the other hand, technical problems related to sample collection and storage and issues related to regulatory and reimburse schemes are expected to hinder the growth of the market.

The fragmented healthcare industry and high operating margins in emerging economies make them attractive to investors when compared to developed economies. Manufacturing these devices products in the developing regions tend to decrease the overall cost of manufacturing, thus reducing the cost of the product without altering the quality.

Middle East & Africa Cardiac Marker Testing Market has been segmented and sub-segmented into the following categories 

  • By Type: Troponin I & T, CK-MB, Myoglobin, BNP, hs-CRP
  • By Product: Reagent, Instrument (Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA))
  • By Disease: Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure
  • By Testing Lab, POC.
  • By Country: KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA

Key Market Participants leading the Middle East & Africa Cardiac Marker Testing Market Profiled in the report are Getinge Group, Medtronic plc, LivaNova PLC, XENIOS Roche Diagnostics Ltd., Abbott Laboratories, Siemens AG, Danaher Corporation, Alere Inc., bioMérieux SA, LSI Medience Corporation, Ortho Clinical Diagnostics, Randox Laboratories Ltd, and Guangzhou Wondfo Biotech Co. Ltd.

1.Introduction          

                1.1 Market Definition

                1.2 Study Deliverables 

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions  

2. Research Methodology                   

                2.1 Introduction       

                2.2 Research Phases  

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design 

                2.4 Study Timeline  

3. Overview               

                3.1 Executive Summary  

                3.2 Key Inferences 

                3.3 Epidemology      

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)            

                4.1 Market Drivers  

                4.2 Market Restraints

                4.3 Key Challenges 

                4.4 Current Opportunities in the Market      

5. Market Segmentation                      

                5.1 Product

                                5.1.1 Introduction                                           

                                5.1.2 Reagents and Kits                                

                                5.1.3 Instruments                                           

  5.1.3.1 Chemiluminescence                        

  5.1.3.2 Immunofluorescence                     

  5.1.3.3 Elisa                        

  5.1.3.4 Immunochromatography                              

                                5.1.4  Y-o-Y Growth Analysis, By Product                                              

                                5.1.5  Market Attractiveness Analysis, By Product                                            

                                5.1.6  Market Share Analysis, By Product                                              

                5.2 Type      

                                5.2.1 Introduction                                           

                                5.2.2 Troponin I & T                                        

                                5.2.3 CK-MB                                      

                                5.2.4 Myoglobin 

                                5.2.5 BNP                                            

                                5.2.6 hsCRP                                        

                                5.2.7 Y-o-Y Growth Analysis, By Type                                     

                                5.2.8 Market Attractiveness Analysis, By Type                                   

                                5.2.9 Market Share Analysis, By Type                                     

                5.3 Disease    

                                5.3.1 Introduction                                           

                                5.3.2 Acute Coronary Syndrome 

                                5.3.3 Myocardial Infarction                                         

                                5.3.4 Congestive Heart Failure                                   

                                5.3.5 Y-o-Y Growth Analysis, By Disease  

                                5.3.6  Market Attractiveness Analysis, By Disease                                             

                                5.3.7  Market Share Analysis, By Disease                                              

                5.4 Type of Testing

                                5.4.1 Introduction                                           

                                5.4.2 Lab                                             

                                5.4.3 Point-Of-Care Testing                                        

                                5.4.4 Y-o-Y Growth Analysis, By Type of Testing 

                                5.4.5  Market Attractiveness Analysis, By Type of Testing                                             

                                5.4.6  Market Share Analysis, By Type of Testing

6. Geographical Analysis                      

                6.1 Introduction       

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

  6.1.3.1 By Geographical Area                     

  6.1.3.2 By Product                           

  6.1.3.3 By Type                 

  6.1.3.4 By Disease                           

  6.1.3.5 By Type of Testing                            

                                6.1.4  Market Attractiveness Analysis                                     

  6.1.4.1 By Geographical Area                     

  6.1.4.2 By Product                           

  6.1.4.3 By Type                 

  6.1.4.4 By Disease                           

  6.1.4.5 By Type of Testing                            

                                6.1.5  Market Share Analysis                                      

  6.1.5.1 By Geographical Area                     

  6.1.5.2 By Product                           

  6.1.5.3 By Type                 

  6.1.5.4 By Disease                           

  6.1.5.5 By Type of Testing                            

                6.2 Middle-East        

                6.3 Africa    

7.Strategic Analysis                

                7.1 PESTLE analysis           

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis      

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                 

                8.1 Getinge Group  

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Medtronic plc    

                8.3 LivaNova PLC     

                8.4 XENIOS Roche Diagnostics Ltd.   

                8.5 Abbott Laboratories 

                8.6 Siemens AG 

                8.7 Danaher Corporation                                                             

                8.8 Alere Inc. 

                8.9 BioMérieux SA  

                8.10 LSI Medience Corporation

9.Competitive Landscape                    

                9.1 Market share analysis    

                9.2 Merger and Acquisition Analysis   

                9.3 Agreements, Collaborations, and Joint Ventures 

                9.4 New Product Launches 

10.Market Outlook and Investment Opportunities                  

Appendix                   

                a) List of Tables  

                b) List of Figures      

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of Type, Product, Disease, and Testing along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the Middle East and Africa Market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensivePESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Cardiac Marker Testing  Market By Type, From 2021 to 2026 ( USD Billion )
  2. Middle East & Africa Troponin I & T Market By Region, From 2021 to 2026 ( USD Billion )
  3. Middle East & Africa Insulin Delivery Market By Region, From 2021 to 2026 ( USD Billion )
  4. Middle East & Africa CK-MB Market By Region, From 2021 to 2026 ( USD Billion )
  5. Middle East & Africa Myoglobin Market By Region, From 2021 to 2026 ( USD Billion )
  6. Middle East & Africa BNP Market By Region, From 2021 to 2026 ( USD Billion )
  7. Middle East & Africa hsCRP Market By Region, From 2021 to 2026 ( USD Billion )
  8. Middle East & Africa Cardiac Marker Testing  Market By Product, From 2021 to 2026 ( USD Billion )
  9. Middle East & Africa Reagent Market By Region, From 2021 to 2026 ( USD Billion )
  10. Middle East & Africa Instrument Market By Region, From 2021 to 2026 ( USD Billion )
  11. Middle East & Africa Chemiluminescence Market By Region, From 2021 to 2026 ( USD Billion )
  12. Middle East & Africa Immunofluorescence Market By Region, From 2021 to 2026 ( USD Billion )
  13. Middle East & Africa Immunochromatography Market By Region, From 2021 to 2026 ( USD Billion )
  14. Middle East & Africa ELISA Market By Region, From 2021 to 2026 ( USD Billion )
  15. Middle East & Africa Cardiac Marker Testing  Market By Disease, From 2021 to 2026 ( USD Billion )
  16. Middle East & Africa Acute Coronary Syndrome Market By Region, From 2021 to 2026 ( USD Billion )
  17. Middle East & Africa Myocardial Infarction Market By Region, From 2021 to 2026 ( USD Billion )
  18. Middle East & Africa Congestive Heart Failure Market By Region, From 2021 to 2026 ( USD Billion )
  19. Middle East & Africa Cardiac Marker Testing  Market By Testing, From 2021 to 2026 ( USD Billion )
  20. Middle East & Africa Lab Market By Region, From 2021 to 2026 ( USD Billion )
  21. Middle East & Africa POC  Market By Region, From 2021 to 2026 ( USD Billion )
  22. Middle East Cardiac Marker Testing  Market By Type, From 2021 to 2026 ( USD Billion )
  23. Middle East Cardiac Marker Testing  Market By Product, From 2021 to 2026 ( USD Billion )
  24. Middle East Cardiac Marker Testing  Market By Disease, From 2021 to 2026 ( USD Billion )
  25. Middle East Cardiac Marker Testing  Market By Testing, From 2021 to 2026 ( USD Billion )
  26. Africa Cardiac Marker Testing  Market By Type, From 2021 to 2026 ( USD Billion )
  27. Africa Cardiac Marker Testing  Market By Product, From 2021 to 2026 ( USD Billion )
  28. Africa Cardiac Marker Testing  Market By Disease, From 2021 to 2026 ( USD Billion )
  29. Africa Cardiac Marker Testing  Market By Testing, From 2021 to 2026 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample